thing that is going to require hard work, not only on the part of the company, but of the global health community to really tackle this serious problem of malaria.SUSAN DENTZER: Under arrangements that will have to be negotiated with global health authorities, GlaxoSmithKline expects that it will be reimbursed for its manufacturing costs, but those funds and other monies for distributing the vacci